This inventor holds 1 USPTO granted patent. Top assignee: Amalive Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Nagaraju Poola: Inventor in Liver-Disease Treatment
Introduction
Nagaraju Poola is an inventor associated with Belle Mead, New Jersey, and Amalive Limited. His patent work concerns ornithine phenylacetate and its potential use in treating hyperammonemia.
Latest Patents
Poola is associated with 1 patent: “Dosages and Uses of Ornithine Phenylacetate for Treating Hyperammonemia.” The patent describes doses and methods of administering ornithine phenylacetate to treat or ameliorate hyperammonemia in patients with chronic liver disease, such as cirrhosis. Some embodiments address patients who also have hepatic encephalopathy.
Career Highlights
Poola’s listed patent reflects work on therapeutic approaches for managing hyperammonemia associated with chronic liver disease. He is associated with Amalive Limited.
Collaborations
The provided information lists Xiaofeng Wang Rears and Jack Tseng as Poola’s coworkers. It does not specify their roles or describe particular joint patent contributions.
Conclusion
Nagaraju Poola’s patent activity centers on ornithine phenylacetate dosing and administration for hyperammonemia, including in patients with chronic liver disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile